Display options
Cite
Olivieri R, Scarnera S, Ciabattini A, et al. Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers. J Occup Med Toxicol. 2016;11:29doi: 10.1186/s12995-016-0117-6.
Olivieri, R., Scarnera, S., Ciabattini, A., De Vuono, G., Manzi, P., Pozzi, G., Battista, G., & Medaglini, D. (2016). Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers. Journal of occupational medicine and toxicology (London, England), 1129. https://doi.org/10.1186/s12995-016-0117-6
Olivieri, Raffaela, et al. "Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers." Journal of occupational medicine and toxicology (London, England) vol. 11 (2016): 29. doi: https://doi.org/10.1186/s12995-016-0117-6
Olivieri R, Scarnera S, Ciabattini A, De Vuono G, Manzi P, Pozzi G, Battista G, Medaglini D. Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers. J Occup Med Toxicol. 2016 Jun 07;11:29. doi: 10.1186/s12995-016-0117-6. eCollection 2016. PMID: 27279894; PMCID: PMC4897955.
Copy Download .nbib Format: NLM
Share it on

J Occup Med Toxicol. 2016 Jun 07;11:29. doi: 10.1186/s12995-016-0117-6. eCollection 2016.

Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers.

Journal of occupational medicine and toxicology (London, England)

Raffaela Olivieri, Sara Scarnera, Annalisa Ciabattini, Giulia De Vuono, Pietro Manzi, Gianni Pozzi, Giuseppe Battista, Donata Medaglini

Affiliations

  1. Laboratorio di Microbiologia Molecolare e Biotecnologia, Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena, Siena, Italy.
  2. Medicina Preventiva e Sorveglianza Sanitaria, Dipartimento di Biotecnologie Mediche, Universita' degli Studi di Siena, Siena, Italy.
  3. Direzione Medica di Presidio, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

PMID: 27279894 PMCID: PMC4897955 DOI: 10.1186/s12995-016-0117-6

Abstract

BACKGROUND: Healthcare workers (HCWs) represent a tuberculosis (TB) risk group for a wide range of tasks in healthcare, even in countries with low TB incidence, like Italy. Latent Tuberculosis Infection (LTBI) screening programs are an important tool for TB prevention in these setting.

METHODS: A retrospective study under a LTBI screening program among HCWs at the Siena University Hospital (Italy), was conducted between September 2011 and July 2015. Tuberculin Skin Test (TST) was used as a first level examination; all TST-positive cases were tested with QuantiFERON-TB Gold In-Tube (QFT-GIT) test, together with a group of TST-negative subjects.

RESULTS: Among the 2136 HCWs screened, 144 (6.7 %) were TST-positive and therefore tested with QFT-GIT, confirming a positive result in 36 cases (25 %). Agreement between two tests was poor (k = 0.092; 95 %, Confidence Interval [CI]- 0.048-0.136, p = 0.002). Among TST-positive cases, discordant results occurred more frequently in BCG vaccinated than unvaccinated HCWs (86.3 %, p < 0.001). The probability of a QFT-GIT-positive result increased according to the TST diameter (p = 0.001). No putative risk factor was associated with LTBI occurrence.

CONCLUSIONS: The use of QFT-GIT test as a second step in TST-positive cases offers an appropriate tool for LTBI detection, especially among BCG-vaccinated HCWs.

Keywords: Healthcare workers; Interferon-gamma release assays; LTBI; Tuberculosis

References

  1. Int J Tuberc Lung Dis. 2014 Sep;18(9):1040-6 - PubMed
  2. Int J Tuberc Lung Dis. 2009 Feb;13(2):196-200 - PubMed
  3. Infect Control Hosp Epidemiol. 2009 Sep;30(9):876-83 - PubMed
  4. Med Sci Monit. 2014 Mar 29;20:521-9 - PubMed
  5. Eur Respir J. 2009 May;33(5):956-73 - PubMed
  6. J Occup Med Toxicol. 2013 May 07;8:12 - PubMed
  7. Eur Respir J. 2011 Jan;37(1):88-99 - PubMed
  8. Biomed Res Int. 2015;2015:746895 - PubMed
  9. Int J Tuberc Lung Dis. 2001 Dec;5(12):1122-8 - PubMed
  10. PLoS Med. 2007 Jun;4(6):e208 - PubMed
  11. Int J Tuberc Lung Dis. 2007 Jun;11(6):593-605 - PubMed
  12. Am J Respir Crit Care Med. 2001 Sep 15;164(6):962-4 - PubMed
  13. Am J Respir Crit Care Med. 2013 Oct 15;188(8):1005-10 - PubMed
  14. Eur Respir J. 2009 Dec;34(6):1423-8 - PubMed
  15. Am J Respir Crit Care Med. 2014 Jan 1;189(1):77-87 - PubMed
  16. Am J Respir Crit Care Med. 1999 Jan;159(1):15-21 - PubMed
  17. MMWR Recomm Rep. 2005 Dec 30;54(RR-17):1-141 - PubMed
  18. J Occup Med Toxicol. 2014 Oct 02;9(1):34 - PubMed
  19. Emerg Infect Dis. 2011 Mar;17(3):488-94 - PubMed
  20. G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):406-7 - PubMed
  21. Euro Surveill. 2009 Oct 29;14(43):null - PubMed
  22. MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25 - PubMed
  23. Tuberculosis (Edinb). 2011 Jul;91(4):322-6 - PubMed
  24. Expert Rev Anti Infect Ther. 2013 Jan;11(1):37-48 - PubMed
  25. Am J Respir Crit Care Med. 2006 Aug 1;174(3):349-55 - PubMed
  26. Thorax. 2012 Jan;67(1):62-70 - PubMed
  27. Ann Clin Lab Sci. 2013 Spring;43(2):221-9 - PubMed

Publication Types